Pehub.com -- Kreatech Diagnostics, a Dutch molecular diagnostics startup, has raised €2 million in new VC funding. Alafi Capital was joined by return backer LSP. The company also named Kees Moonen, former CEO of Green Cross Vaccine, as its new CEO.